Blog
3 High-Yield Stocks for Conservative Investors
High-yield stocks are generally off limits for risk-averse investors because they tend to be fundamentally unsound types of equities, bringing with them high debt loads, falling top lines, and so....
Payer Pushback Is Weighing Down Retail Pharmacy Stocks
Prescription volume is climbing at Walgreens Boots Alliance (NASDAQ: WBA) and CVS Health (NYSE: CVS), yet growth rates at these pharmacy retailers are slowing. Why aren't retail pharmacies....
2 Tesla Talking Points: A Vegas Forecast and a Potential Win for AMD
In this Market Foolery podcast segment, host Chris Hill gets the lowdown from Motley Fool Asset Management's Bill Barker about the Deutsche Bank Technology Conference he attended last week in Las....
Scholastic's Latest Quarter Was Cursed by Tough Harry Potter Comparisons
In this Market Foolery podcast segment, host Chris Hill and Motley Fool Asset Management's Bill Barker look at the latest readout from children's book giant Scholastic (NASDAQ: SCHL), which....
The Creative Ways Drugmakers Are Delaying Generics
Drugmakers are increasingly embracing new tactics to protect billions of dollars in sales from generic competition. These strategies often involve patent trials, but that's not the only way....
KB Home's Board Is Serious About Quelling CEO Scandals
In this Market Foolery podcast segment, host Chris Hill and Motley Fool Asset Management's Bill Barker consider how an activist board reacts when an exec embarrasses the company. KB Home (NYSE:....
With GM’s President Selling Shares, What Should Investors Do?
In this Market Foolery podcast segment, host Chris Hill and Motley Fool Hidden Gems' Abi Malin take a listener query about General Motors (NYSE: GM) and broaden it: Are stock sales from in and....
Early Evidence That the Amazon-Whole Foods Merger Is a Picture Perfect Marriage
Amazon.com's (NASDAQ: AMZN) purchase of Whole Foods Market looks like a match made in heaven. The first indication the two could be on an extended honeymoon comes from the immediate boost in sales....
Ask a Fool: Why Do Drugmakers Do Interim Clinical Trials?
The cost of clinical trials jumps significantly when drugmakers move from phase 1 to phase 2 and phase 2 to phase 3. To reduce research and development costs, drugmakers are increasingly embracing....
Expect Higher Dividends Before 2017 Ends From These 3 Stocks
Many of the best dividend stocks in the market have impressive track records of growing their payouts over time. A select few have even gotten to the point at which investors can predict exactly....
3 Reasons to Buy the Dip With Exelixis
In just two days, Exelixis (NASDAQ: EXEL) has lost over 15% of its market cap. The tumble for the once-hot biotech stock started last week with a downgrade of the stock by an analyst at Leerink....
Experts Are Watching This Number at Enbridge Inc
Enbridge Inc (NYSE: ENB) is a Canadian oil and gas midstream giant that sports an impressive 4.6% yield -- well more than twice what the broader market is offering investors today. It has big....
How Safe Is Brown-Forman's Dividend?
Dividend investors like reliable businesses, and the alcohol and spirits industry has been a reliable producer of profits for centuries. Brown-Forman (NYSE: BF-A) (NYSE: BF-B) isn't a household....
Caveat Emptor When Buying High-Yield Drug Stocks
Income investors seemingly have hundreds of stocks to choose from that currently pay a dividend. The telecom and utility sectors often generate some of the most robust payouts for investors, with....
3 High Dividend Yields That Are Here to Stay
The oil and natural gas midstream industry is filled with high yields. But not all high yields are created equal, as the 40% distribution cut at Enbridge Energy Partners in 2017 and the 75%....
Just How Rich Is Mark Cuban?
Mark Cuban is well-known for his tenure on Shark Tank. With a net worth of several billion dollars, he is by far the wealthiest of the "shark" investors. Cuban made his fortune during the dot-com....
Intel's New Desktop Processor Is No Threat to NVIDIA
On Monday, Intel Corporation (NASDAQ: INTC) raised eyebrows across the tech world by unveiling its new 8th Gen Intel Core desktop processor family. Perhaps most notably, the central processing....
How Low Does Valeant Pharmaceuticals' Debt Really Need to Go?
There's as much of a chance that Valeant Pharmaceuticals (NYSE: VRX) wipes out its debt of nearly $28.5 billion anytime soon as there is of Donald Trump receiving a birthday present from football....
Has Anheuser-Busch Finally Had Its Fill of Craft Beer?
Too much of a good thing can be, well, too much. Anheuser-Busch InBev (NYSE: BUD) has been chugging down so many pint-sized craft breweries that it is giving itself a bad hangover from the binge,....
Total Continues Its Look Beyond Fossil Fuels to Renewable Energy
No oil major has done more to build a renewable energy business than Total (NYSE: TOT). It owns two-thirds of solar manufacturer SunPower (NASDAQ: SPWR), bought battery maker Saft last year for....
PQ Group Holdings IPO: What Investors Need to Know
Is the second time the charm? PQ Group Holdings, a sprawling company that produces a wide range of inorganic chemicals, undoubtedly hopes so. It's about to launch an IPO, not long after it....
5 Numbers That Should Get MannKind Investors Excited
MannKind (NASDAQ: MNKD) hasn't exactly given investors a whole lot to get excited about in recent years. That could be changing, though. Since May, MannKind stock has soared more than 130% and now....
3 Bargain Biotech Stocks You Can Buy Today
You might have heard that the stock market is overpriced after years of solid gains. And it is. That doesn't mean every stock is overpriced, though.Actually, several biotech stocks look....
3 Reasons Ciena Corporation Is Staying Ahead of the Competition
In researching my latest article on Ciena's (NYSE: CIEN) recent quarter, I found a lot to like about the company. As Foolish investors, we are always on the lookout for companies with outstanding....
What the IRS Should Do Now to Protect Taxpayers From Fraud
The recent data breach at Equifax is just the latest reminder of the threat that identity theft poses. Although most people are aware of the possibility of having their credit cards used....